1. Home
  2. ANTX vs HGBL Comparison

ANTX vs HGBL Comparison

Compare ANTX & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANTX
  • HGBL
  • Stock Information
  • Founded
  • ANTX 2017
  • HGBL 1937
  • Country
  • ANTX United States
  • HGBL United States
  • Employees
  • ANTX N/A
  • HGBL N/A
  • Industry
  • ANTX Biotechnology: Pharmaceutical Preparations
  • HGBL Business Services
  • Sector
  • ANTX Health Care
  • HGBL Consumer Discretionary
  • Exchange
  • ANTX Nasdaq
  • HGBL Nasdaq
  • Market Cap
  • ANTX 63.5M
  • HGBL 60.6M
  • IPO Year
  • ANTX 2022
  • HGBL N/A
  • Fundamental
  • Price
  • ANTX $1.07
  • HGBL $1.64
  • Analyst Decision
  • ANTX Buy
  • HGBL
  • Analyst Count
  • ANTX 4
  • HGBL 0
  • Target Price
  • ANTX $2.50
  • HGBL N/A
  • AVG Volume (30 Days)
  • ANTX 204.5K
  • HGBL 99.0K
  • Earning Date
  • ANTX 11-07-2024
  • HGBL 11-07-2024
  • Dividend Yield
  • ANTX N/A
  • HGBL N/A
  • EPS Growth
  • ANTX N/A
  • HGBL N/A
  • EPS
  • ANTX N/A
  • HGBL 0.30
  • Revenue
  • ANTX N/A
  • HGBL $55,019,000.00
  • Revenue This Year
  • ANTX N/A
  • HGBL N/A
  • Revenue Next Year
  • ANTX N/A
  • HGBL $20.19
  • P/E Ratio
  • ANTX N/A
  • HGBL $5.47
  • Revenue Growth
  • ANTX N/A
  • HGBL N/A
  • 52 Week Low
  • ANTX $0.87
  • HGBL $1.52
  • 52 Week High
  • ANTX $22.22
  • HGBL $3.53
  • Technical
  • Relative Strength Index (RSI)
  • ANTX 39.40
  • HGBL 42.80
  • Support Level
  • ANTX $1.03
  • HGBL $1.58
  • Resistance Level
  • ANTX $1.09
  • HGBL $1.72
  • Average True Range (ATR)
  • ANTX 0.04
  • HGBL 0.07
  • MACD
  • ANTX 0.03
  • HGBL 0.01
  • Stochastic Oscillator
  • ANTX 66.67
  • HGBL 55.41

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a global full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

Share on Social Networks: